Medworld Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 27-12-2024
- Paid Up Capital ₹ 0.38 M
as on 27-12-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.19 Cr
as on 27-12-2024
- Satisfied Charges ₹ 9.67 Cr
as on 27-12-2024
- Revenue -12.16%
(FY 2020)
- Profit 2610.20%
(FY 2020)
- Ebitda -32.33%
(FY 2020)
- Net Worth 51.43%
(FY 2020)
- Total Assets 8.34%
(FY 2020)
About Medworld Pharmaceuticals
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.38 M.
The company currently has active open charges totaling ₹3.19 Cr. The company has closed loans amounting to ₹9.67 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishnan Kannan and Hema Kannan serve as directors at the Company.
- CIN/LLPIN
U24239MH2006PTC162744
- Company No.
162744
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medworld Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishnan Kannan  | Director | 10-Jul-2006 | Current |
| Hema Kannan | Director | 20-May-2009 | Current |
Financial Performance of Medworld Pharmaceuticals.
Medworld Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 12.16% decrease. The company also saw a substantial improvement in profitability, with a 2610.2% increase in profit. The company's net worth Soared by an impressive increase of 51.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medworld Pharmaceuticals?
In 2020, Medworld Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novacare Drug Specialities Private LimitedActive 32 years 6 monthsRamakrishnan Kannan and Hema Kannan are mutual person
- Novacare Packaging Private LimitedActive 25 years 8 months
Ramakrishnan Kannan and Hema Kannan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Jul 2013 | ₹3.19 Cr | Open |
Others Creation Date: 07 Nov 2019 | ₹1.49 Cr | Satisfied |
Others Creation Date: 12 May 2018 | ₹4.78 Cr | Satisfied |
How Many Employees Work at Medworld Pharmaceuticals?
Unlock and access historical data on people associated with Medworld Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medworld Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medworld Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
